Trial Profile
Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Enoxaparin sodium; Fondaparinux sodium
- Indications Deep vein thrombosis
- Focus Adverse reactions; Therapeutic Use
- 21 Dec 2015 New trial record